All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-1122-YF7927 | Anti-VEGFR2 (XW-567) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-567 | Human | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7928 | Anti-VEGFR2 (XW-568) h(CD28-41BB-CD3ζ) CAR, pAAV | Mouse | XW-568 | Rat | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7929 | Anti-VEGFR2 (XW-569) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-569 | Mouse | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7930 | Anti-VEGFR2 (XW-570) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-570 | Mouse | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-0123-ZP157 | Anti-VEGFR2 (AC88) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | AC88 | Human | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP158 | Anti-VEGFR2 (Ramucirumab) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | Ramucirumab | Human | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP159 | Anti-VEGFR2 (Bevacizumab) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | Bevacizumab | Human | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP490 | Anti-VEGFR2 (89B3A5) h(scFv-CD3ε) TRuC, pCDTRC1 | Mouse | 89B3A5 | Rat | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP750 | Anti-VEGFR2 (KDR1121) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | KDR1121 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP751 | Anti-VEGFR2 (DC101) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | DC101 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP752 | Anti-VEGFR2 (Avas12α1) h(scFv-CD3ε) TRuC, pCDTRC1 | Mouse | Avas12α1 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP753 | Anti-VEGFR2 (2C6) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | 2C6 | Human | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP157 | Anti-VEGFR2 (AC88 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | AC88 | Human | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP158 | Anti-VEGFR2 (Ramucirumab scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | Ramucirumab | Human | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP159 | Anti-VEGFR2 (Bevacizumab scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | Bevacizumab | Human | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP490 | Anti-VEGFR2 (89B3A5 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Mouse | 89B3A5 | Rat | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP750 | Anti-VEGFR2 (KDR1121 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | KDR1121 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP751 | Anti-VEGFR2 (DC101 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | DC101 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP752 | Anti-VEGFR2 (Avas12α1 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Mouse | Avas12α1 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP753 | Anti-VEGFR2 (2C6 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | 2C6 | Human | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION